Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl in Schedule I
scheduling · Rule · Final rule. · Published 2019-05-08 · 84 FR 20023
Document
Document number
2019-09479
Federal Register citation
84 FR 20023
Type
Rule
Action
Final rule.
Category
scheduling
Publication date
2019-05-08
Abstract
With the issuance of this final rule, the Drug Enforcement Administration places beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2- (thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide), also known as N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl- propanamide, including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. This rule continues the imposition of the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle beta-hydroxythiofentanyl.